1. Efficacy and Safety of Docetaxel and Sodium Cantharidinate Combination vs. Either Agent Alone as Second-Line Treatment for Advanced/Metastatic NSCLC With Wild-Type or Unknown EGFR Status: An Open-Label, Randomized Controlled, Prospective, Multi-Center Phase III Trial (Cando-L1)
   Lin Wu et al, 2021, Frontiers in Oncology CrossRef
2. Combination of Sodium Cantharidinate with Cisplatin Synergistically Hampers Growth of Cervical Cancer
   Xiangxun Chen et al, 2021, Drug Design, Development and Therapy CrossRef
3. Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma
   Yubo Xiang et al, 2023, Frontiers in Oncology CrossRef